InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Shankar Gopi. Director active across 1 company, notably Larimar Therapeutics, Inc.. Cumulatively, 3 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €17k. History available since 7 December 2023. The latest transaction was disclosed on 22 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations